Thinking Allowed
medical / technology / education / art / flub
showing posts for 'pharmaceutical companies'
Biopharma futures
I've been looking at a few industry reports on the future of biopharma as part of a course I'm on with INSEAD Business School on Business Strategy and Financial Performance. I thought I'd share some of my ramblings on Biopharma Futures. Expectations are high Pharmaceutical
companies are operating...
Source: agnate.co.uk
Factors affecting the uptake of new medicines: a systematic literature review - BMC Health Services Research Lublóy, Ágnes.
"This systematic literature review has provided insights into the factors that affect new drug uptake—primarily, doctors’ scientific orientation, prescribing habits, exposure to pharmaceutical marketing, and interpersonal communication." "Background The successful diffusion of new drugs is crucial...
Source: biomedcentral.com
Publication bias is a challenge in science and a criticism of the influence of industry.
Publication bias is a challenge in science and a criticism of the influence of industry. In the domain of biosciences and drug development more accountability (e.g. the FDAAA 2007), editorial and peer-review training (as suggested by the Cochrane Collaboration), and statistical techniques (as championed...
A critical makeover for pharmaceutical companies: Overcoming industry obstacles with a cross-functional strategy. PwC
A critical makeover for pharmaceutical companies: Overcoming industry obstacles with a cross-functional strategy. PwC report. Going all "cross-functional" or "breaking down silos"?
"Compounding the external obstacles, however, is the internal culture of most pharma companies. This is an industry...
Source: pwc.com
Development of new antibiotics encouraged with new pharmaceutical payment system: The NHS will test the world's first ‘subscription’
Development of new antibiotics encouraged with new pharmaceutical payment system: The NHS will test the world's first ‘subscription’ style payment model to incentivise pharmaceutical companies to develop new drugs for resistant infections.
"The new trial will be led by the National Institute for...
Source: www.gov.uk
EU Trials Tracker — Who's not sharing clinical trial results? : By law, all clinical trials on the European Union
EU Trials Tracker — Who's not sharing clinical trial results?
:
By law, all clinical trials on the European Union Clinical Trials Register
(EUCTR) must report their results in the registry within a year of completion.
This site tracks which universities and pharmaceutical companies are...
Source: trialstracker.net
1 in 12 doctors accepts payment from pharmaceutical companies related to opioids: One in twelve physicians -- and nearly
1 in 12 doctors accepts payment from pharmaceutical companies related to opioids: One in twelve physicians -- and nearly one in five family medicine physicians -- accepted payments from pharmaceutical companies related to opioids, according to a new study out of Boston Medical Center's Grayken Center...
Source: eurekalert.org
RSS feed